Robinson Cano Positive PED Test Good For Mets
The Mets had real issues regarding roster construction and much of it was related to Robinson Cano. His presence was a complication forcing a number of bad decisions.
With Cano at second, Jeff McNeil was displaced from the position he played best. That meant he moved to third where his arm didn’t translate well or left field.
If he was in left field, that meant Brandon Nimmo moved to center where he was ill suited. Really, every permutation of the lineup necessitated Nimmo in CF.
The Mets have two everyday caliber first basemen in Pete Alonso and Dominic Smith. If Cano needed to DH, that meant both first basemen played in the field.
That moved the Mets best defensive first baseman in Smith to left where he’s not particularly good. That was exacerbated by Alonso being a poor defensive first baseman.
Really, when you look at it, the necessity to play Cano and his $20.25 million salary just forces a series of terrible decisions. That’s a large reason why the Mets never hit their supposed ceiling – the defense was that bad and held the team back.
Now, with Cano gone for the 2021 season much of the Mets problems have been solved.
McNeil can now be the everyday second baseman. Nimmo can then go back to a corner outfield position where he belongs. Assuming the return of the DH, Alonso can DH with Smith at first.
As if this wasn’t good enough, the Mets have an additional $20.25 million to allocate towards their holes at catcher, third, center, and the pitching staff.
Every way you look at this, Cano testing positive is good news for the Mets, and that’s even before you account for any regression you should’ve expected from the now 38 year old. If this invites a buy out, this could make the situation even better.
With one incredibly poor decision by Cano, the Mets defense has been substantially improved, and they have enough resources to sign up to two additional impact players they may not have been otherwise able to sign. That’s why Cano’s positive test is great news for the Mets.